Tengion's replacement bladders could enter clinical trials as early as next year
By Gregory Mone
Posted 05.20.2008 at 2:20 pm 1 Comment
A company called Tengion announced recently that its full-size, neo-bladder replacements performed well in large animal models. Tengion's technology - the commercialized version of the work of Anthony Atala - is based around the idea that it's better to use the patient's own cells to try to grow replacement organs and tissues, since transplants from donors often lead to rejection.
Five amazing, clean technologies that will set us free, in this month's energy-focused issue. Also: how to build a better bomb detector, the robotic toys that are raising your children, a human catapult, the world's smallest arcade, and much more.